Ipamorelin Peptide History
Ipamorelin was discovered in the early 1990s by Novo Nordisk, a Danish pharmaceutical company. It was derived from GHRP-1, another growth hormone secretagogue (GHS) peptide. GHRP-1 was known to have a number of side effects, such as increased cortisol levels and hunger, so Novo Nordisk scientists sought to develop a more selective and safer GHS […]
Ipamorelin Peptide History Read More »